---
title: "Fidia boosts capital as GGHL converts bonds and receives new warrants"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276912037.md"
description: "Fidia S.p.A. has issued a second tranche of its 2026 convertible bond loan with Global Growth Holding Limited, comprising 25 bonds worth €250,000 and 2.5 million warrants. GGHL converted 15 bonds at €0.09 per share, leading to the issuance of 1,666,666 new shares and increasing Fidia's capital to €10,247,761.90. The total number of shares now stands at 34,631,817. The latest analyst rating for Fidia stock (IT:FDA) is a Sell with a price target of €0.11."
datetime: "2026-02-25T15:52:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276912037.md)
  - [en](https://longbridge.com/en/news/276912037.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276912037.md)
---

# Fidia boosts capital as GGHL converts bonds and receives new warrants

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Fidia Spa ( (IT:FDA) ) just unveiled an announcement.

Fidia S.p.A. has issued and placed with Global Growth Holding Limited the second tranche of its 2026 convertible bond loan with warrants, comprising 25 bonds with a nominal value of €250,000 and 2.5 million attached warrants exercisable into shares at €0.10. The warrants, which are not listed and have a 60‑month duration, bring total outstanding POC-related warrants to 5 million, reinforcing a structured financing route designed to support the group’s capital needs.

On the same date, GGHL requested and obtained conversion of 15 of these bonds at €0.09 per share, resulting in the issuance of 1,666,666 new Fidia shares directly admitted to trading, and lifting the subscribed capital increase for the POC to €400,000. Following this partial conversion, Fidia’s share capital rises by €150,000 to €10,247,761.90, with the total number of shares increasing to 34,631,817, signalling ongoing balance-sheet strengthening and a deeper equity stake for its financial partner.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

**More about Fidia Spa**

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading global provider of numerical control technology and high-performance integrated milling systems. With more than 40 years of experience and around 135 employees, it focuses on advanced solutions for the automotive mould sector and the aerospace industry, offering numerical controls, high-speed milling machines and CAM software for complex shapes.

**Average Trading Volume:** 956,877

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** €3.3M

Find detailed analytics on FDA stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [8713.JP](https://longbridge.com/en/quote/8713.JP.md)

## Related News & Research

- [FIDEA Unveils Three-year Plan Tied to Shonai–Hokuto Merger and Regional Growth](https://longbridge.com/en/news/286504433.md)
- [Fidia Issues 1 Million New Shares After Bond Conversion Under 2026 POC](https://longbridge.com/en/news/280837811.md)
- [TABLE-EU Commission sells 3-month EU-Bills at average yield of 2.189%](https://longbridge.com/en/news/287046315.md)
- [Treasury yields top 5% as bonds outshine stocks in forecasts](https://longbridge.com/en/news/287212854.md)
- [U.S. 9-yr 8-mo indexed notes high yield 2.169%](https://longbridge.com/en/news/287254647.md)